We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
1051
Relay Therapeutics
RLAY
$4.37B
$103K 0.01%
19,700
+3,100
+19% +$11.8K
CCIIU
1052
Cohen Circle Acquisition Corp II Unit
CCIIU
$103K 0.01%
+10,000
New +$102K
AHCO icon
1053
AdaptHealth
AHCO
$696M
$102K 0.01%
+11,441
New +$106K
SLDP icon
1054
Solid Power
SLDP
$536M
$102K 0.01%
+29,400
New +$111K
BACC
1055
Blue Acquisition Corp
BACC
$292M
$100K 0.01%
+10,000
New +$99.8K
PLCE icon
1056
Children's Place
PLCE
$58.3M
$99.2K 0.01%
+15,972
New +$86.7K
ONTF
1057
DELISTED
ON24
ONTF
$97.2K 0.01%
17,000
+4,300
+34% +$23.1K
VZLA
1058
Vizsla Silver
VZLA
$1.36B
$96.8K 0.01%
22,417
-29,250
-57% -$101K
ASTL icon
1059
Algoma Steel
ASTL
$468M
$95.1K 0.01%
+26,758
New +$142K
ACH
1060
Accendra Health
ACH
$107M
$93.6K 0.01%
+19,503
New +$124K
TARA icon
1061
Protara Therapeutics
TARA
$231M
$93.6K 0.01%
21,516
-1,300
-6% -$4.21K
FIGS icon
1062
FIGS
FIGS
$2.39B
$91.7K 0.01%
+13,700
New +$90.4K
KAZR
1063
Skyline Builders Group
KAZR
$60.5M
$91K 0.01%
+26,598
New +$51.9K
AKBA icon
1064
Akebia Therapeutics
AKBA
$234M
$89.7K 0.01%
32,840
-8,869
-21% -$29.5K
NKTX icon
1065
Nkarta
NKTX
$176M
$89.6K 0.01%
+43,300
New +$88.9K
GBTG icon
1066
American Express Global Business Travel
GBTG
$4.94B
$88.9K 0.01%
11,000
-29,963
-73% -$222K
CDXS icon
1067
Codexis
CDXS
$161M
$87.7K 0.01%
+35,927
New +$98K
DEFT
1068
Defi Technologies
DEFT
$178M
$87.4K 0.01%
+41,419
New +$107K
AMWL icon
1069
American Well
AMWL
$231M
$86.1K 0.01%
+14,005
New +$103K
RES icon
1070
RPC Inc
RES
$1.36B
$86K 0.01%
+18,065
New +$85.3K
QTRX icon
1071
Quanterix
QTRX
$114M
$83.6K 0.01%
15,393
-1,491
-9% -$7.93K
INGN icon
1072
Inogen
INGN
$163M
$82.2K 0.01%
+10,058
New +$75.2K
CLYM
1073
Climb Bio
CLYM
$778M
$81.8K 0.01%
+40,718
New +$75.6K
ARCO icon
1074
Arcos Dorados Holdings
ARCO
$1.7B
$81K 0.01%
11,997
-2,171
-15% -$15.4K
LX
1075
LexinFintech Holdings
LX
$242M
$80K 0.01%
+15,000
New +$95.9K
41 42
43
44 45

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.